Newsmeme!
Discover News you didn't know existed
Transduction
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Genomics in China
Published January 7, 2009, 8:53 pm, News-Medical-Net
Ten years ago, the Chinese National Human Genome Center at Shanghai (South Center, hereafter) was established in the Zhangjiang HiTech Park of Pudong District in Shanghai.
Human genomics in China
Published January 7, 2009, 6:48 am, EurekAlert!
( Science in China Press ) The latest special issue of Science in China Series C: Life Sciences focuses on the human genome project in China, and it coordinately explore the trend and goal of the future development of this academic discipline.
High Growth Reported for the World Cell/Tissue Culture Supplies Market
Published January 6, 2009, 5:55 am, Business Wire via Yahoo! Finance
NEW YORK----Reportlinker.com announces that a new market research report related to the Laboratory equipment industry is available in its catalogue.
Examine the World Biotechnology Reagents Market
Published January 6, 2009, 5:46 am, Business Wire via Yahoo! Finance
NEW YORK----Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue.
Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor Of CK2
Published January 6, 2009, 3:16 am, Medical News Today
Cylene Pharmaceuticals announced that it has initiated a Phase I clinical trial of its oral CK2 protein kinase inhibitor, CX-4945, in patients with advanced solid tumors, Castleman's disease, or multiple myeloma. The primary endpoints of the oral dose escalating trial are determination of safety, tolerance and PK properties of CX-4945 and to select the appropriate dose for Phase II trials.
Cylene Pharmaceuticals starts CX-4945 trial - first-in class inhibitor of CK2
Published January 5, 2009, 8:07 pm, News-Medical-Net
Cylene Pharmaceuticals announced today that it has initiated a Phase I clinical trial of its oral CK2 protein kinase inhibitor, CX-4945, in patients with advanced solid tumors, Castleman's disease, or multiple myeloma.
Merck Serono: Study Published In JCO Shows Erbitux Enhances Efficacy In MCRC Patients With KRAS Wild-Type Tumors In ...
Published January 5, 2009, 8:14 am, Medical News Today
A study published today in the Journal of Clinical Oncology demonstrates that the addition of Erbitux® (cetuximab) to standard oxaliplatin-based chemotherapy (FOLFOX-4) in previously untreated metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors results in significantly higher efficacy than chemotherapy alone.
Calcium flickers steer cell migration
Published January 5, 2009, 5:53 am, Nature
Directional movement is a property common to all cell types during development and is critical to tissue remodelling and regeneration after damage. In migrating cells, calcium has a multifunctional role in directional sensing, cytoskeleton redistribution, traction force generation, and relocation of focal adhesions. Here we visualize high-calcium microdomains (|[lsquo]|calcium flickers|[rsquo]|) ...
Casein kinase 1|[agr]| governs antigen-receptor-induced NF-|[kgr]|B activation and human lymphoma cell survival
Published January 5, 2009, 5:50 am, Nature
The transcription factor NF-|[kgr]|B is required for lymphocyte activation and proliferation as well as the survival of certain lymphoma types. Antigen receptor stimulation assembles an NF-|[kgr]|B activating platform containing the scaffold protein CARMA1 (also called CARD11), the adaptor BCL10 and the paracaspase MALT1 (the CBM complex), linked to the inhibitor of NF-|[kgr]|B kinase complex, ...
Cleveland BioLabs Reports Advances In Curaxin Anticancer Program
Published January 2, 2009, 5:16 am, Medical News Today
Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced several advances in the development of Curaxins, the leading class of drug candidates in the Company's anticancer drug discovery program. Curaxins are synthetic small molecules designed to simultaneously target major stress response pathways that are frequently deregulated in cancer.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |